Inappropriate gonadotropin secretion in polycystic ovary syndrome: Influence of adiposity

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 11, 1997, Pages 3728-3733

  Arroyo, A ^a   Laughlin, G A ^a   Morales, A J ^a   Yen, S S C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GLUCOSE; GONADORELIN; GONADOTROPIN; INSULIN; LUTEINIZING HORMONE;

ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CONTROLLED STUDY; ECTOPIC HORMONE PRODUCTION; FEMALE; GONADOTROPIN RELEASE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE;

EID: 0030698381     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.11.3728     Document Type: Article

References (53)

1. Yen SSC, Vela P, Rankin J. 1970 Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab. 30:435-442.
2. Rebar R, Judd HL, Yen SSC, Rakoff J, VandenBerg G, Naftolin F. 1976 Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest. 57:1320-1329.
3. Yen SSC. 1980 Polycystic ovary syndrome. Clin Endocrinol (Oxf). 12:177-208.
4. Burger CW, Schoemaker J. 1985 Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea. J Clin Endocrinol Metab. 61:1126-1132.
5. Kazer R, Yen SCC. 1987 Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 65:233-236.
6. Filicori M, Campaniello E, Michelacci L, et al. 1988 Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH. J Clin Endocrinol Metab. 66:327-333.
7. Venturoli S, Porcu E, Fabbri R, et al. 1988 Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone, and LH circadian variations in polycystic ovary syndrome. Clin Endocrinol (Oxf). 28:93-107.
8. Couzinet B, Thomas G, Thalabard JC, Brailly S, Schaison G. 1989 Effects of a pure antiandrogen on gonadotropin secretion in normal women and in polycystic ovarian disease. Fertil Steril. 52:42-50.
9. Graf MA, Bielfeld P, Distter W, Weiers C, Kuhn-Velten W. 1993 Pulsatile luteinizing hormone secretion pattern inhyperandrogenic women. Fertil Steril. 59:761-767.
10. Waldstreicher J, Santoro NF, Hall JE, Filicori M, Crowley, Jr, WF. 1988 Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab. 66:165-172.
11. Christman GM, Randolph JF, Kelch RP, Marshall JC. 1991 Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease. J Clin Endocrinol Metab. 72:1278-1285.
12. Berga SL, Guzick DS, Winters SJ. 1993 Increased luteinizing hormone and alpha-subunit secretion in women with hyperandrogenic anovulation. J Clin Endocrinol Metab. 77:895-901.
13. Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SSC. 1996 Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab. 81:2854-2864.
14. Apter D, Bützow T, Laughlin GA, Yen SSC. 1994 Accelerated 24-h LH pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome. J Clin Endocrinol Metab. 79:119-125.
15. Apter D, Bützow T, Laughlin GA, Yen SSC. 1995 Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab. 80:2966-2973.
16. Yen SSC, Chaney C, Judd HL. 1976 Functional aberrations of the hypothalamic-pituitary system in polycystic ovary syndrome: a consideration of the pathogenesis. In: Serio M, ed. The endocrine function of the human ovary. New York: Academic Press; 373-385.
17. Huffman JW. 1976 Polycystic ovaries in young girls. Proc of the 3rd Int Symp on Pediatric and Adolescent Gynecol. pp 193-206.
18. Venturoli S, Porcu E, Fabbri R, et al. 1986 Ovarian multifollicularity, high LH and androgen plasma levels and anovulation are frequent and strongly linked in adolescent irregular cycles. Acta Endocrinol (Copenh). 111:368-373.
19. Franks S. 1989 Polycystic ovary syndrome: a changing perspective. Clin Endocrinol (Oxf). 31:87-120.
20. Conway GS, Honour JW, Jacobs H. 1989 Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf). 30:459-470.
21. Zawadzki JK, Dunaif A. 1992 Diagnostic criteria: towards a rational approach. In: Hershmann JM, ed. Current issues in endocrinology and metabolism. Boston: Blackwell Scientific Publications; 377-384.
22. Conway GS, Jacobs H, Holly JM, Wass JA. 1990 Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin like growth factor small binding protein 1 in the polycystic ovary syndrome. Clin Endocrinol (Oxf). 33:593-603.
23. Anttila L, Ding YQ, Ruutiainen K, Erkkola R, Irjala K, Huhtaniemi I. 1991 Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease. Fertil Steril. 55:1057-1061.
24. Dale PO, Tanbo T, Vaaler S, Abyholm T. 1992 Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil Steril. 58:487-491.
25. Grulet H, Hecart AC, Delemar B, et al. 1993 Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome. Clin Endocrinol (Oxf). 38:621-626.
26. Holte J, Bergh T, Gennarelli G, Wide L. 1994 The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotropins and sex steroids in premenopausal women. Clin Endocrinol (Oxf). 41:473-481.
27. Givens JR, Andersen RA, Umstot ES, Wiser WL. 1976 Clinical findings and hormonal responses in patients with polycystic ovarian disease with normal versus elevated LH levels. Obstet Gynecol. 47:388-394.
28. Laatikainen A, Tulenheimo A, Andersson B, Karkkaninen J. 1983 Obesity, serum steroid levels, and pulsatile gonadotropin secretion in polycystic ovarian disease. Eur J Obstet Gynecol Reprod Biol. 15:45-53.
29. Paradisi R, Venturoli S, Pasquali R, et al. 1986 Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease. J Endocrinol Invest. 9:139-144.
30. Smith S, Ravnikar VA, Barbieri RL. 1987 Androgen and insulin response to an oral glucose challenge in hyperandrogenic women. Fertil. Steril. 48:72-77.
31. Laughlin GA, Morales AJ, Yen SSC. 1997 Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance / hyperinsulinemia. J Clin Endocrinol Metab. 82:1692-1696.
32. Bergman RN, Prager R, Volund A, Olefsky JM. 1987 Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 79:790-800.
33. Veldhuis JD, Johnson ML. 1986 Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol. 250:E486-E493.
34. Kopelman PG. 1994 Hormones and obesity. Balliere's Clin Endocrinol Metab. 8:549-575.
35. Dunaif A, Graf M. 1989 Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J Clin Invest. 83:23-29.
36. Nestler JE, Cornelius OB, Mat DW, et al. 1989 Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 68:1027-1032.
37. Kiddy DS, Hamilton-Fairley D, Bush A, et al. 1992 Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 36:105-111.
38. Holte J, Bergh T, Berne C, Wide L, Hans L. 1995 Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 80:2586-2593.
39. Velasquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. 1994 Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism. 53:647-654.
40. Nestler JE, Jakubowicz D. 1996 Decreases in ovarian cytochrome P450c17alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med. 335:617-622.
41. Velasquez EM, Mendoza SG, Wang P, Glueck CJ. 1997 Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein (a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. Metabolism. 46:454-457.
42. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb F. 1996 The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab. 81:3299-3306.
43. Ehrmann DA, Schneider DJ, Sobel BE, et al. 1997 Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 82:2108-2116.
44. Chapman IM, Wittert GA, Norman RG. 1997 Circulating leptin in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Clin Endocrinol (Oxf). 46:175-181.
45. Mantzoros CS, Dunaif A, Flier JS. 1997 Leptin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab. 82:1687-1691.
46. Rouru J, Antilla A, Koskinen F, et al. 1997 Serum leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 82:1697-1700.
47. Antilla L, Ding Y-Q, Ruutianen K, Erkkola R, Irjala K, Huhtaniemi I. 1991 Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease. Fertil Steril. 55:1057-1061.
48. Robinson S, Rodin DA, Deacon A, Wheeler MJ, Clayton RN. 1992 Which hormone tests for the diagnosis of polycystic ovary syndrome? Br J Obstet Gynecol. 99:232-238.
49. Obhrai M, Lynch SS, Holder G, Jackson R, Tang L, Butt WR. 1990 Hormonal studies on women with polycystic ovaries diagnosed by ultrasound. Clin Endocrinol (Oxf). 32:467-474.
50. Quigley ME, Yen SSC. 1980 The role of endogenous opiates on LH secretion during the menstrual cycle. J Clin Endocrinol Metab. 51:179-181.
51. Berga SL, Yen SSC. 1989 Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 30:177-184.
52. Kazer RR, Liu CH, Yen SSC. 1987 Dependence of mean levels of circulating luteinizing hormone upon pulsatile amplitude and frequency. J Clin Endocrinol Metab. 65:796-800.
53. Apter D, Bützow T, Laughlin GA, Yen SSC. 1994 Increasing the clinical value of serum LH measurements by reducing short term variation. Presented at the 20th Spring Meeting of the Finnish Endocrine Society. Tallin, Estonia, 1994.